1. Moellendorff E van, Abshagen U, Akpan W, Neugebauer G, Schroeter E (19869 Clinical pharmacologic investigations with carvedilol, a new beta-blocker with direct vasodilator activity. Clin Pharmacol Ther 39: 677?682
2. Strein K, Sponer B, Mueller-Beckmann B, Bartsch W (1987) Pharmacological profile of a carvedilol, a compound with beta-blocking and vasodilating properties. J Cardiovasc Pharmacol 10 [Suppl 11]: S33-S41
3. Abshagen U (1987) A new molecule with vasodilating and beta-adrenoceptor blocking properties. J Cardiovasc Pharmacol 10 [Suppl 11]: S23-S32
4. Cubeddu LX, Fuenmayer N, Varin F, Villagra VG, Colindres RE, Powell JR (1987) Mechanism of the vasodil-ory effect of carvedilol in normal volunteers: a comparison with labetaolol. J Cardiovasc Pharmacol 10 [Suppl 11]: S81-S84
5. Hashimoto H, Tanaka M, Kanda A, Akashi A (1988) Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats. Drugs 26 [Suppl 6]: 31?36